Skip to main content

Table 3 Summary of sources used to extract information on age appropriate NTD formulations

From: Drugs for neglected tropical diseases: availability of age-appropriate oral formulations for young children

Database

Weblink

‘Summary of Product Characteristics’ (SPCs) for medicines licensed for human use in the UK

https://www.medicines.org.uk/emc/

US FDA reviews and approved labels for products licensed for human use in the US

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm)

‘European public assessment reports’ (EPAR) for products approved by the EMA

https://www.ema.europa.eu/en/medicines/field_ema_web_categories%253Aname_field/Human

‘WHO Public Assessment Reports’ (WHO PAR) for drugs prequalified by WHO)

https://extranet.who.int/pqweb/medicines/prequalified-lists/finished-pharmaceutical-products

Drugbank: a web-enabled database containing comprehensive molecular information about drugs, their mechanisms, their interactions and their targets [55]

Information on product shape, colour and size is also available

https://go.drugbank.com/

Product literature’ (labels/prescribing information) provided by the companies marketing the products on websites or as ‘package inserts’ have to be those approved by the relevant regulatory authority

Â